v3.24.3
Share-Based Compensation
9 Months Ended
Sep. 30, 2024
Share Based Compensation  
Share-Based Compensation

8.           Share-Based Compensation

As part of the Redomiciliation, Kiniksa International assumed the sponsorship of, and all rights and obligations of Kiniksa Bermuda under Kiniksa Bermuda’s equity compensation plans, which include the 2018 Incentive Award Plan (the “2018 Plan”), 2018 Employee Share Purchase Plan (the “2018 ESPP”), and Rilonacept Long-Term Incentive Plan (“RLTIP”) which was approved under the 2018 Plan. Upon the effectiveness of the 2018 Plan, the Company ceased granting awards under its 2015 Equity Incentive Plan (as amended, the “2015 Plan” and together with the 2018 Plan, the “Plans”).

2015 Plan

As of September 30, 2024, there were 1,558,781 Class A ordinary shares reserved for issuance pursuant to outstanding awards under the 2015 Plan that were granted prior to the effectiveness of the 2018 Plan.

2018 Plan

The 2018 Plan provides for the grant of incentive share options, nonqualified share options, share appreciation rights, restricted shares, dividend equivalents, restricted share units (“RSUs”) and other share- or cash- based awards. Pursuant to the 2018 Plan’s evergreen provision, the number of shares available for future issuance under the 2018 Plan, as of January 1, 2024, increased by 2,818,425 Class A ordinary shares. As of September 30, 2024, 5,086,871 shares remained available for future grant under the 2018 Plan.

2018 ESPP

In December 2023, the Company’s board of directors approved an increase, as of January 1, 2024, of 215,000 Class A ordinary shares under the 2018 ESPP. As of September 30, 2024, 671,515 Class A ordinary shares were available for future issuance under the 2018 ESPP.

Options

Share option activity under the Plans is summarized as follows:

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

Number of

​

Average

​

​

Shares

​

Exercise Price

Outstanding as of December 31, 2023

 

11,599,089

​

$

13.67

Granted

 

1,688,275

​

$

22.08

Exercised

 

(1,214,398)

​

$

11.15

Forfeited

 

(444,291)

​

$

16.07

Outstanding as of September 30, 2024

 

11,628,675

​

$

15.06

Share options exercisable as of September 30, 2024

 

7,613,209

​

$

14.01

Share options unvested as of September 30, 2024

 

4,015,466

​

$

17.06

​

As of September 30, 2024, total unrecognized compensation expense related to the unvested share option awards was $42,841 which is expected to be recognized over a weighted average remaining period of 2.58 years.

​

Restricted Share Units

​

The Company grants RSUs with service conditions (“Time-Based RSUs”) to eligible employees as part of its equity incentive compensation. The Time-Based RSUs vest 25% on each of the first, second, third and fourth anniversaries of the date of grant, subject to continued employment through such dates.

During the years ended December 31, 2020 and 2019, the Company granted the first RSU awards (“First RLTIP RSU Awards”) as part of the RLTIP to eligible employees. During the year ended December 31, 2021, the FDA Milestone (as defined in RLTIP) was achieved (the date of such achievement, the “Achievement Date”) and (1) the number of Class A ordinary shares issuable under the First RLTIP RSU Awards were determined in accordance with the RLTIP and vested in one installment in March 2022, and (2) the Company granted a second set of RSU awards to eligible employees on the Achievement Date with respect to a number of shares determined in accordance with the RLTIP, which vested in one installment in March 2023.

​

The following table summarizes RSU activity, including the RSUs issued under the RLTIP for the nine months ended September 30, 2024:

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

Average

​

​

Number of

​

Grant Date

​

​

Shares

​

Fair Value

Unvested RSUs as of December 31, 2023

​

2,396,888

​

$

14.00

Granted

​

937,767

​

$

22.08

Vested

​

(603,762)

​

$

13.80

Forfeited

​

(345,616)

​

$

14.72

Unvested RSUs as of September 30, 2024

​

2,385,277

​

$

17.12

​

As of September 30, 2024, total unrecognized compensation cost related to the RSU awards was $36,441 which is expected to be recognized over a weighted average remaining period of 2.78 years.

Market and Performance-Based Shares Units

In the second quarter of 2024, the Company began periodically granting performance-based restricted share units to certain employees under the 2018 Plan. The Company granted awards which are earned based upon the achievement of certain specified ARCALYST revenue targets (“Revenue PSUs”), and awards which are earned based upon the Company’s total shareholder return (“TSR”) relative to the TSR of each member of a specified peer group (“TSR PSUs” and, together with the Revenue PSUs, the “PSUs”). The PSUs are subject to a three year service period.

The following table summarizes PSU activity for the nine months ended September 30, 2024:

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

Average

​

​

Number of

​

Grant Date

​

​

Shares

​

Fair Value

Unvested PSUs as of December 31, 2023

​

-

​

$

-

Granted

​

62,914

​

$

22.06

Forfeited

​

(3,777)

​

$

22.06

Unvested PSUs as of September 30, 2024

​

59,137

​

$

22.06

​

As of September 30, 2024, total unrecognized compensation cost related to the PSU awards was $1,522 which is expected to be recognized over a weighted average remaining period of 2.25 years.

Share-Based Compensation

Share-based compensation expense was classified in the consolidated statements of operations and comprehensive loss as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Nine Months Ended

​

​

September 30, 

​

September 30, 

​

    

2024

    

2023

​

2024

    

2023

Cost of goods sold

​

$

447

​

$

493

​

$

1,159

​

$

1,090

Research and development expenses

​

​

1,608

​

​

1,273

​

​

4,562

​

​

4,112

Selling, general and administrative expenses

​

 

5,771

​

 

5,022

​

 

16,674

​

 

14,174

​

​

$

7,826

​

$

6,788

​

$

22,395

​

$

19,376

​